Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Internal Medicine (Tokyo, Japan)
|
August 6, 2025
Low Generic Drug Penetration for Expensive Oral Molecular Targeted Agents: An Experience with Generic Imatinib in Japan
Keisuke Kidoguchi, Hiroshi Ureshino, Shinya Kimura
Cancer Science
|
January 21, 2025
Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine
Tatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura
Ejhaem
|
December 18, 2024
IFN-α treatment may enable discontinuation of TKIs in NK cell-licensed patients with CML-CP
Hiroshi Ureshino, Kazuharu Kamachi, Keisuke Kidoguchi, et al.
Cancer Medicine
|
August 11, 2025
Clinical Features and T-Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC-TFR Study
Hiroshi Ureshino, Yukio Nakamura, Yemima Budirahardja, et al.
International Journal of Molecular Sciences
|
October 26, 2024
Targeting Oxidative Phosphorylation with a Novel Thiophene Carboxamide Increases the Efficacy of Imatinib against Leukemic Stem Cells in Chronic Myeloid Leukemia
Kana Kusaba, Tatsuro Watanabe, Keisuke Kidoguchi, et al.
International Journal of Hematology
|
April 28, 2021
Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute
Keisuke Kidoguchi, Hiroshi Ureshino, Haruna Kizuka-Sano, et al.
Cancers
|
October 28, 2023
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
Kazunori Kawasoe, Tatsuro Watanabe, Nao Yoshida-Sakai, et al.
International Journal of Hematology
|
March 19, 2020
Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor
Toshihiko Ando, Haruna Sano, Masako Yokoo, et al.
Internal Medicine (Tokyo, Japan)
|
May 17, 2021
Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome
Keisuke Kidoguchi, Yasushi Kubota, Shun Fujimoto, et al.
Internal Medicine (Tokyo, Japan)
|
September 18, 2024
Pure Red Cell Aplasia in a Patient with Thymic Hyperplasia, Hypogammaglobulinemia and Adult T-cell Leukemia/Lymphoma
Yasushi Kubota, Haruhiko Sano, Yuji Takeda, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Internal Medicine (Tokyo, Japan)
|
August 6, 2025
Low Generic Drug Penetration for Expensive Oral Molecular Targeted Agents: An Experience with Generic Imatinib in Japan
Keisuke Kidoguchi, Hiroshi Ureshino, Shinya Kimura
Cancer Science
|
January 21, 2025
Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine
Tatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura
Ejhaem
|
December 18, 2024
IFN-α treatment may enable discontinuation of TKIs in NK cell-licensed patients with CML-CP
Hiroshi Ureshino, Kazuharu Kamachi, Keisuke Kidoguchi, et al.
Cancer Medicine
|
August 11, 2025
Clinical Features and T-Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC-TFR Study
Hiroshi Ureshino, Yukio Nakamura, Yemima Budirahardja, et al.
International Journal of Molecular Sciences
|
October 26, 2024
Targeting Oxidative Phosphorylation with a Novel Thiophene Carboxamide Increases the Efficacy of Imatinib against Leukemic Stem Cells in Chronic Myeloid Leukemia
Kana Kusaba, Tatsuro Watanabe, Keisuke Kidoguchi, et al.
International Journal of Hematology
|
April 28, 2021
Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute
Keisuke Kidoguchi, Hiroshi Ureshino, Haruna Kizuka-Sano, et al.
Cancers
|
October 28, 2023
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
Kazunori Kawasoe, Tatsuro Watanabe, Nao Yoshida-Sakai, et al.
International Journal of Hematology
|
March 19, 2020
Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor
Toshihiko Ando, Haruna Sano, Masako Yokoo, et al.
Internal Medicine (Tokyo, Japan)
|
May 17, 2021
Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome
Keisuke Kidoguchi, Yasushi Kubota, Shun Fujimoto, et al.
Internal Medicine (Tokyo, Japan)
|
September 18, 2024
Pure Red Cell Aplasia in a Patient with Thymic Hyperplasia, Hypogammaglobulinemia and Adult T-cell Leukemia/Lymphoma
Yasushi Kubota, Haruhiko Sano, Yuji Takeda, et al.
Page
of 3